It is also worth noting that there are a number of members of the Ras subfamily of GTPases which are frequently mutated in human cancers, including HRAS, NRAS and most commonly, KRAS, with activating Ras mutations found in ∼20% of cancer patients [195,196]. This evidence concerns the gene NRAS and cancer.